US Patent 7335658 Pyridazine derivatives and their use as therapeutic agents
Patent 7335658 was granted and assigned to Xenon Pharmaceuticals on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+19 properties)
Infobox
Patent Inventor Names
Chi Tu0
Duanjie Hou0
Heinz W Gschwend0
Jian-Min Fu0
Mark W Holladay0
Melwyn Abreo0
Michael D Winther0
Mikhail Chafeev0
Nagasree Chakka0
Rajender Kamboj0
Sengen Sun0
Serguei Sviridov0
Shaoyi Sun0
Shifeng Liu0
Sultan Chowdhury0
Vandna Raina0
Vishnumurthy Kodumuru0
Wenbao Li0
Zaihui Zhang0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+217 characters)
Article
Patent abstract
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I):
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07335658 Pyridazine derivatives and their use as therapeutic agents US Patent 7335658 Pyridazine derivatives and their use as therapeutic agents
Infobox
Patent Number
07335658
Patent Number
7335658
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07335658 Pyridazine derivatives and their use as therapeutic agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07335658
Date of patent
February 26, 2008
Patent application number
10901563
Date Filed
July 29, 2004
Patent primary examiner
Find more entities like US Patent 7335658 Pyridazine derivatives and their use as therapeutic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
